OBJECTIVE: Ovarian cancer has the highest mortality rate cancer worldwide in women, and it is the second most common gynecologic malignancy in females, but the treatment remained unsatisfactory. Researches showed that lncRNA EBIC had played key roles in different cancer, but its role in ovarian cancer remains largely unclear. PATIENTS AND METHODS: qRT-PCR was applied … Continue reading LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients